Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 1.86M
2: EX-4.5 Instrument Defining the Rights of Security Holders HTML 44K
6: EX-10.10 Material Contract HTML 96K
7: EX-10.11 Material Contract HTML 30K
8: EX-10.12 Material Contract HTML 94K
9: EX-10.16 Material Contract HTML 97K
10: EX-10.17 Material Contract HTML 49K
11: EX-10.18 Material Contract HTML 86K
3: EX-10.2 Material Contract HTML 101K
4: EX-10.6 Material Contract HTML 86K
5: EX-10.9 Material Contract HTML 94K
12: EX-21.1 Subsidiaries List HTML 25K
13: EX-23.1 Consent of Expert or Counsel HTML 23K
17: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 41K Awarded Compensation
14: EX-31.1 Certification -- §302 - SOA'02 HTML 28K
15: EX-31.2 Certification -- §302 - SOA'02 HTML 29K
16: EX-32.1 Certification -- §906 - SOA'02 HTML 27K
23: R1 Cover Page HTML 90K
24: R2 Audit Information HTML 29K
25: R3 Consolidated Balance Sheets HTML 124K
26: R4 Consolidated Balance Sheets (Parenthetical) HTML 52K
27: R5 Consolidated Statements of Operations and HTML 90K
Comprehensive Loss
28: R6 Consolidated Statements of Operations and HTML 27K
Comprehensive Loss (Parenthetical)
29: R7 Consolidated Statements of Changes in HTML 148K
Stockholders? Equity
30: R8 Consolidated Statements of Changes in HTML 31K
Stockholders? Equity (Parenthetical)
31: R9 Consolidated Statements of Cash Flows HTML 147K
32: R10 Description of Business HTML 32K
33: R11 Summary of Significant Accounting Policies HTML 66K
34: R12 Investments and Fair Value Measurements HTML 89K
35: R13 Property and Equipment HTML 37K
36: R14 Accrued Liabilities HTML 37K
37: R15 Debt HTML 47K
38: R16 Collaboration Agreements HTML 38K
39: R17 Commitments and Contingencies HTML 48K
40: R18 Capital Stock HTML 70K
41: R19 Warrants HTML 70K
42: R20 Share-Based Compensation HTML 77K
43: R21 Retirement Benefit Plan HTML 26K
44: R22 Net Loss Per Share HTML 38K
45: R23 Income Taxes HTML 74K
46: R24 Subsequent Events HTML 27K
47: R25 Pay vs Performance Disclosure HTML 36K
48: R26 Insider Trading Arrangements HTML 41K
49: R27 Summary of Significant Accounting Policies HTML 120K
(Policies)
50: R28 Investments and Fair Value Measurements (Tables) HTML 94K
51: R29 Property and Equipment (Tables) HTML 36K
52: R30 Accrued Liabilities (Tables) HTML 37K
53: R31 Debt (Tables) HTML 40K
54: R32 Commitments and Contingencies (Tables) HTML 32K
55: R33 Warrants (Tables) HTML 51K
56: R34 Share-Based Compensation (Tables) HTML 76K
57: R35 Net Loss Per Share (Tables) HTML 36K
58: R36 Income Taxes (Tables) HTML 69K
59: R37 Description of Business (Details) HTML 41K
60: R38 Summary of Significant Accounting Policies HTML 41K
(Details)
61: R39 INVESTMENTS AND FAIR VALUE MEASUREMENTS - HTML 50K
Investments (Details)
62: R40 INVESTMENTS AND FAIR VALUE MEASUREMENTS - HTML 28K
Narrative (Details)
63: R41 INVESTMENTS AND FAIR VALUE MEASUREMENTS - Fair HTML 69K
Value Measurements (Details)
64: R42 PROPERTY AND EQUIPMENT - Components of Property HTML 41K
and Equipment (Details)
65: R43 PROPERTY AND EQUIPMENT - Narrative (Details) HTML 26K
66: R44 ACCRUED LIABILITIES - Components of Accrued HTML 44K
Liabilities (Details)
67: R45 DEBT - Narrative (Details) HTML 82K
68: R46 DEBT - Schedule of Long-Term Debt Instruments HTML 44K
(Details)
69: R47 DEBT - Schedule of Future Principal Payments HTML 47K
(Details)
70: R48 Collaboration Agreements (Details) HTML 52K
71: R49 Commitments and Contingencies (Details) HTML 98K
72: R50 Commitments and Contingencies - Future Lease HTML 38K
Payments under Noncancelable Leases (Details)
73: R51 Capital Stock (Details) HTML 127K
74: R52 WARRANTS - Stock Warrants Outstanding (Details) HTML 43K
75: R53 WARRANTS - Stock Warrant Activity (Details) HTML 35K
76: R54 SHARE-BASED COMPENSATION - Narrative (Details) HTML 82K
77: R55 SHARE-BASED COMPENSATION - Balance by Plans HTML 55K
(Details)
78: R56 SHARE-BASED COMPENSATION - Stock Option Activity HTML 86K
(Details)
79: R57 SHARE-BASED COMPENSATION - Fair Value Assumption HTML 44K
for Stock Options (Details)
80: R58 SHARE-BASED COMPENSATION - Allocation of HTML 31K
Share-based Compensation Expense on Statements of
Operations (Details)
81: R59 Retirement Benefit Plan (Details) HTML 29K
82: R60 NET LOSS PER SHARE - Summary of Potential Dilutive HTML 40K
Securities (Details)
83: R61 INCOME TAXES - Effective Tax Rate Reconciliation HTML 42K
(Details)
84: R62 INCOME TAXES - Components of Deferred Tax Assets HTML 58K
and Liabilities (Details)
85: R63 INCOME TAXES - Narrative (Details) HTML 46K
86: R64 Subsequent Events (Details) HTML 42K
88: XML IDEA XML File -- Filing Summary XML 143K
91: XML XBRL Instance -- vrdn-20231231_htm XML 1.61M
87: EXCEL IDEA Workbook of Financial Report Info XLSX 169K
19: EX-101.CAL XBRL Calculations -- vrdn-20231231_cal XML 186K
20: EX-101.DEF XBRL Definitions -- vrdn-20231231_def XML 732K
21: EX-101.LAB XBRL Labels -- vrdn-20231231_lab XML 1.91M
22: EX-101.PRE XBRL Presentations -- vrdn-20231231_pre XML 1.11M
18: EX-101.SCH XBRL Schema -- vrdn-20231231 XSD 165K
89: JSON XBRL Instance as JSON Data -- MetaLinks 521± 772K
90: ZIP XBRL Zipped Folder -- 0001590750-24-000007-xbrl Zip 1.20M
‘EX-97.1’ — Clawback Policy re: Recovery of Erroneously Awarded Compensation
It is the policy of Viridian Therapeutics, Inc. (the “Company”) that, in the event the Company is required to prepare an accounting restatement of the
Company’s financial statements due to material non-compliance with any financial reporting requirement under the federal securities laws (including any such correction that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period), the Company will recover on a reasonably prompt basis the amount of any Incentive-Based Compensation Received by a Covered Executive during the Recovery Period that exceeds the amount that otherwise would have been Received had it been determined based on the restated financial statements (each as defined below). This Incentive Compensation Clawback Policy (this “Policy”) has been adopted by the
Company’s Board of Directors (the “Board”) effective October 11, 2023 (the “Effective Date”). The Board may amend or change the terms of this Policy at any time for any reason, including as required to comply with any laws, rules, regulations and listing standards that may be applicable to the Company.
Policy Administration and Definitions
This Policy is administered by the Compensation Committee of the Board (the “Committee”), subject to ratification by the Board with respect to final determinations related to Covered Executive compensation. The Policy is intended to comply with, and as applicable to be administered
and interpreted consistent with, and subject to the exceptions set forth in, Listing Rule 5608 adopted by the Nasdaq Stock Market (“Nasdaq”) to implement Rule 10D-1 under the Securities Exchange Act of 1934, as amended (collectively, “Rule 10D-1”).
For the purposes of this Policy:
•“Covered Executive” means any “executive officer” of the Company as defined under Rule 10D-1.
•A “Financial Reporting Measure” is (i) any measure that is determined and presented in accordance with the
accounting principles used in preparing the Company’s financial statements and any measure derived wholly or in part from such a measure, and (ii) any measure based in whole or in part on the Company’s stock price or total shareholder return.
•“Incentive-Based Compensation” means any compensation granted, earned or vested based in whole or in part on the Company’s attainment of a Financial Reporting Measure that was Received by a person (i) on or after the Effective Date and after the person began service as a Covered Executive, and (ii) who served as a Covered Executive at any time during the performance
period for the Incentive-Based Compensation.
•Incentive-Based Compensation is deemed to be “Received” in the fiscal period during which the relevant Financial Reporting Measure is attained, regardless of when the compensation is actually paid or awarded.
•“Recovery Period” means the three completed fiscal years immediately preceding the date that the Company is required to prepare the accounting restatement described
in this Policy and any transition period of less than nine months that is within or immediately following such three fiscal years, all as determined pursuant to Rule 10D-1.
Determination by the Committee
If the Committee determines the amount of Incentive-Based Compensation Received by a Covered Executive during a Recovery Period exceeds the amount that would have been Received if determined or calculated based on the Company’s restated financial results, such excess amount of Incentive-Based Compensation shall be subject to recoupment by the Company pursuant to this Policy. For Incentive-Based Compensation based on stock price or total shareholder return, where the amount of erroneously awarded compensation is
not subject to mathematical recalculation directly from the information in an accounting restatement, the Committee will determine the amount based on a reasonable estimate of the effect of the accounting restatement on the relevant stock price or total shareholder return. In all cases, the calculation of the excess amount of Incentive-Based Compensation to be recovered will be determined on a pre-tax basis (i.e., without regard to any taxes paid with respect to such compensation). The Company will maintain and will provide to Nasdaq documentation of all determinations and actions taken in complying with this Policy. All determinations made by the Committee or the Board under this Policy shall be final and binding on all affected individuals.
Methods of Clawback
The
Company may effect any recovery pursuant to this Policy in any manner consistent with applicable law, including by requiring payment of such amount(s) to the Company, by set- off, by reducing future compensation, or by such other means or combination of means as the Committee determines to be appropriate. The Company need not recover the excess amount of Incentive-Based Compensation if and to the extent that the Committee determines that such recovery is impracticable, subject to and in accordance with any applicable exceptions under the Nasdaq listing rules and not required under Rule 10D-1, including if the Committee determines that the direct expense paid to a third party to assist in enforcing this Policy would exceed the amount to be recovered after making a reasonable attempt to recover
such amounts. The Company is authorized to take appropriate steps to implement this Policy with respect to Incentive-Based Compensation arrangements with Covered Executives.
Not Exclusive Remedy
Any right of recoupment or recovery pursuant to this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company pursuant to the terms of any other policy, any employment agreement or plan or award terms, and any other legal remedies available to the Company (including, but not limited to, Section 304 of the Sarbanes-Oxley Act of 2002);
provided that the Company shall not recoup amounts pursuant to such other policy, terms or remedies to the extent it is recovered pursuant to this Policy. The Company shall not indemnify any Covered Executive against (i) any liability or loss (including without limitation the loss of any Incentive-Based Compensation pursuant to this Policy, including any payment or reimbursement for the cost of third-party insurance purchased by any Covered Executives to fund potential recovery obligations under this Policy, any judgments, fines, taxes, penalties or amounts paid in settlement by or on behalf of any Covered Executive) incurred by such Covered Executive in connection with or as a result of any action taken by the Company
to enforce this Policy (a “Clawback Proceeding”) or (ii) any
indemnification or advancement of expenses (including attorneys’ fees) incurred by such Covered Executive in connection with any such Clawback Proceeding.
Certification
All Covered Executives subject to this Policy will be required to certify their understanding of and intent to comply with this Policy periodically.
By signing below, the undersigned covered executive (the “Covered Executive”) acknowledges and confirms that the
Covered Executive has received and reviewed a copy of the Viridian Therapeutics, Inc. (the “Company”) Incentive Compensation Clawback Policy (the “Policy”), and in addition, the Covered Executive acknowledges and agrees that, for good and valid consideration, including continuing participation in the Company’s incentive compensation programs, the receipt and sufficiency of which the Covered Executive hereby acknowledges, the Covered Executive will be bound by and abide by the Policy as follows:
(a)the Covered Executive is and will continue to be subject to the Policy and the Policy will apply both during and after the Covered Executive’s employment with the
Company;
(b)to the extent necessary to comply with the Policy, the Company hereby amends any employment agreement, equity award agreement or similar agreement that the Covered Executive is a party to with the Company;
(c)the Covered Executive shall abide by the terms of the Policy, including, without limitation, by returning any compensation to the Company to the extent required by, and in a manner permitted by, the Policy, and understands and agrees that the
Company is not permitted to, and will not, indemnify the Covered Executive for any liability, loss, including loss of any compensation that is subject to recovery by the Company, or expenses nor will the Company advance any expenses (including attorneys’ fees) incurred as a result of any action by or on behalf of the Company pursuant to the Policy and the Covered Executive hereby knowingly and intentionally waives and agrees not to assert any claim for indemnification or advancement of expenses against the Company or any subsidiary of the Company
to which the Covered Executive is now or may become entitled notwithstanding any other agreement or provision therefor;
(d)any amounts payable to the Covered Executive shall be subject to the Policy as may be in effect and interpreted or modified from time to time in the discretion of the Company’s Board of Directors or Compensation Committee or as required by applicable law or the requirements of any securities exchange on which the Company’s securities are listed, and that such interpretation or modification will be covered by this acknowledgment;
(e)the
Company may recover compensation paid to the Covered Executive through any method of recovery the Compensation Committee or its delegate deems appropriate, including without limitation by reducing any amount that is or may become payable to the Covered Executive, and the Covered Executive agrees to comply with any request or demand for repayment by the Company in order to comply with the Policy; and
(f)the Company is not responsible for and shall not make the Covered Executive whole for any effect under any tax law or regulation of the recovery of any compensation pursuant to the Policy, or for any taxes paid by the Covered Executive on compensation that is subject to recovery or is recovered pursuant
to the Policy.
_________________________
Signature
__________________________
Print Name & Date
[ACKNOWLEDGMENT AND CERTIFICATION]
Dates Referenced Herein and Documents Incorporated by Reference
